A new drug binds a cell-surface G-protein-coupled receptor and activates adenylate cyclase, raising intracellular cyclic AMP. Which class of downstream effector is most directly activated by this second messenger?
Show answer and explanation
Answer: B Protein kinase A
The receptor described is coupled to Gs. Activated Gαs stimulates adenylate cyclase, which converts ATP to cyclic AMP. Cyclic AMP binds the regulatory subunits of protein kinase A, which release its catalytic subunits. These then phosphorylate target proteins such as enzymes, ion channels and the transcription factor CREB. Examples include β-adrenergic receptors (increased heart rate and contractility, glycogenolysis), glucagon receptors and TSH receptors. It helps to keep the three main GPCR pathways separate: Gs raises cAMP and activates PKA; Gi inhibits adenylate cyclase and lowers cAMP; Gq activates phospholipase C, producing IP3 (calcium release) and DAG (protein kinase C). Cholera toxin locks Gs on and pertussis toxin blocks Gi, and both are common exam links.
- Key clue
- Gs-coupled receptor raising cyclic AMP
- What it means
- Classic Gs-adenylate cyclase-cyclic AMP-protein kinase A pathway
- What to do
- Protein kinase A is the direct downstream effector of cyclic AMP
Why the other options are less appropriate
- A Phospholipase C sits in the Gq pathway, producing IP3 and DAG. It is not activated by cyclic AMP.
- C Receptor tyrosine kinases (such as insulin and growth-factor receptors) dimerise and autophosphorylate when their ligand binds. They do not use cyclic AMP.
- D Guanylate cyclase makes cyclic GMP, which activates protein kinase G. It is driven by nitric oxide or natriuretic peptides, not by cyclic AMP.
- E Steroid hormone receptors are intracellular and act directly on gene transcription. They are unrelated to the GPCR–cAMP pathway.